Alembic Pharmaceuticals Limited

1,028

INR
+8.50(+0.83%)
As of November 14, 2024 10:00:00 AM

Alembic Pharmaceuticals Limited Share Price Information

24 hour Low and High

Low: 1020.15
High: 1035

All time High

1247.70

Price Change 1h

+₹-6.95 +-0.67%

Price Change 1d

+₹-6.95 +-0.67%

Price Change 1w

+₹-51.90 +-4.81%

Alembic Pharmaceuticals Limited Market Information

Exchange

NSE

Market Cap

21298.59 Cr

About Alembic Pharmaceuticals Limited Share

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

14858

CEO

Mr. Chirayu Ramanbhai Amin

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts
  • UPL, Hindustan Copper, Alembic Pharma & CUB: These are 4 top stock picks by SMC Global
  • Alembic Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Alembic Pharma shares touch all-time high after Q1 net profit surges over 11% YoY
  • Indian drugmaker Alembic Pharma misses Q2 profit view as US sales growth slows

FAQs

Alembic Pharmaceuticals Limited

1,028

INR
+8.50(+0.83%)
As of November 14, 2024 10:00:00 AM

Alembic Pharmaceuticals Limited Share Price Information

24 hour Low and High

Low: 1020.15
High: 1035

All time High

1247.70

Price Change 1h

+₹-6.95 +-0.67%

Price Change 1d

+₹-6.95 +-0.67%

Price Change 1w

+₹-51.90 +-4.81%

Alembic Pharmaceuticals Limited Market Information

Exchange

NSE

Market Cap

21298.59 Cr

About Alembic Pharmaceuticals Limited Share

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

14858

CEO

Mr. Chirayu Ramanbhai Amin

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts
  • UPL, Hindustan Copper, Alembic Pharma & CUB: These are 4 top stock picks by SMC Global
  • Alembic Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Alembic Pharma shares touch all-time high after Q1 net profit surges over 11% YoY
  • Indian drugmaker Alembic Pharma misses Q2 profit view as US sales growth slows

FAQs